Riskpilot← Back to searchSign inGet full accessWolfbrandt & Malmros AB
ABActiveOrg 5592053366Economic activity was not specified by tax authority · NACE 0000Est. 20190 employees
Revenue 2024
SEK 0
EBITDA margin
—
0% vs 2023
Equity ratio
89.2%
Financial strength
Net profit 2024
SEK 999K
0% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | +0% |
| Net profit | SEK 999K | +0% |
| Total assets | SEK 6M | +0% |
| Equity | SEK 5,4M | -7% |
| Employees | 0 | — |
Legal name
Wolfbrandt & Malmros AB
Org number
5592053366
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
13 maj 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget har till föremål förs in verksamhet att bedriva sjukvård, försäljning av sjukvårdsrelaterade produkter samt därmed förenlig verksamhet.
Address
Email
susanne@adrakliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 | −1 | −1 | −1 | −1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −1 | −1 | −1 | −1 | −1 |
| Net financials | 2 951 | 2 500 | 2 000 | 1 000 | 1 000 |
| Profit before tax | 3 000 | 2 499 | 1 999 | 999 | 999 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 3 000 | 2 499 | 1 999 | 999 | 999 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 015 | 6 550 | 6 637 | 6 000 | 6 001 |
| Equity | 5 359 | 6 306 | 6 637 | 5 765 | 5 352 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 656 | 244 | 0 | 235 | 649 |
| Total debt | 656 | 244 | — | 235 | 649 |
EBITDA margin
-100000.0%
This company
15.8%
Market median
-633011% vs market
20202024
Equity ratio
89.2%
This company
38.2%
Market median
+134% vs market
20202024
Return on equity
18.7%
This company
18.4%
Market median
+2% vs market
20202024
Net profit margin
99900000.0%
This company
8.1%
Market median
+1233333233% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EC | Audit | 2024 |
| Former (1) | ||
KG Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Wolfbrandt & Malmros AB 
Ådrakliniken ABBoard members of Wolfbrandt & Malmros AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Chris Nettervik Carlsson | Audit | 0 companies |
| Kjell Göran Carlsson | Audit | 0 companies |
| Karl Emil Gustaf Svensson | Deputy Board Member | 0 companies |
| Elsa Susanne Lindholm | Chairman | 0 companies |
| Johan Stig Philip Ryott Malmros | Deputy Board Member | 0 companies |
| Ulla Annika Wolfbrandt | Board of Directors | 0 companies |